Acasti Pharma Competitors and Similar CompaniesClear all
Acasti Pharma's competitors and similar companies include Amarin, Cipla, CSL Behring and Biogen.
 Acasti Pharma Acasti is a biopharmaceutical company focused on the research, development, and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. |  Amarin Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ||
Founding Date | Founding Date 2002 | Founding Date 1991 | Founding Date 1935 | Founding Date 1904 | Founding Date 1978 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Laval, CA HQ Laval, CA New York, US | Locations Dublin, IE HQ Zug, CH Bridgewater Township, US | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 32 | Employees 275 | Employees 27,764 | Employees 7,5692% decrease | Employees 7,605 |
Valuation ($) | Valuation ($) 34.2 m | Valuation ($) 257.6 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 26.7 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $228.6m (FY, 2024) | Revenue (est.) ₹254.5b (FY, 2024) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $9.7b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹88.2b (FY, 2024) | Cost of goods N/A | Cost of goods $2.3b (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit $81.4m (FY, 2024) | Gross profit ₹169.5b (FY, 2024) | Gross profit $4.5b (FY, 2020) | Gross profit $7.4b (FY, 2024) |
Net income | Net income ($12.9m) (FY, 2024) | Net income ($82.2m) (FY, 2024) | Net income ₹41.6b (FY, 2024) | Net income N/A | Net income $1.6b (FY, 2024) |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) 110 (FY, 2020) | Patents (US) N/A | Patents (US) N/A | Patents (US) 21 (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Amarin
HQ
Dublin, IE
Employees
275
Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyBiogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company